About Brabant Pharma
Brabant Pharma is a company based in San Francisco (United States) founded in 2013 was acquired by Zogenix in October 2014.. Brabant Pharma offers products and services including emPura, Sông Lam Oil, Hupavir Sinecatechin, and Myovit 3. Brabant Pharma operates in a competitive market with competitors including Alnylam, Ultragenyx, BioMarin Pharmaceutical, Mirum Pharmaceuticals and Homology Medicines, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brabant Pharma
Brabant Pharma offers a comprehensive portfolio of products and services, including emPura, Sông Lam Oil, Hupavir Sinecatechin, and Myovit 3. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Foam for intimate hygiene and cleaning based on safety standards
Oil for reducing joint pain and inflammation
Capsules for immune support and health maintenance
Eye drop solution for relieving discomfort and irritation
Funding Insights of Brabant Pharma
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2013 | Amount | Series A - Brabant Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Brabant Pharma
Brabant Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Zogenix and Aquarius Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Science focused VC firm investing in the US & UK
|
Founded Year | Domain | Location | |
|
Drug delivery systems for CNS disorders and pain are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Brabant Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Brabant Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Brabant Pharma Comparisons
Competitors of Brabant Pharma
Brabant Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alnylam, Ultragenyx, BioMarin Pharmaceutical, Mirum Pharmaceuticals and Homology Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic diseases are developed by BioMarin Pharmaceutical.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for rare diseases treatment.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for rare genetic diseases
|
|
| domain | founded_year | HQ Location |
Orally deliverable bradykinin B2 antagonists are developed for hereditary angioedema.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Brabant Pharma
When was Brabant Pharma founded?
Brabant Pharma was founded in 2013.
Where is Brabant Pharma located?
Brabant Pharma is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
What does Brabant Pharma do?
Brabant Pharma was founded in 2013 in San Francisco, United States, with a focus on therapeutics for rare central nervous system disorders. The lead product, Brabafen, a low-dose fenfluramine formulation, was advanced to Phase 3 trials for pediatric Dravet Syndrome, a severe epilepsy form. Orphan drug status was obtained from U.S. and European regulators. Acquisition by Zogenix was completed in October 2014.
Who are the top competitors of Brabant Pharma?
Brabant Pharma's top competitors include Alnylam, UniQure and BioMarin Pharmaceutical.
What products or services does Brabant Pharma offer?
Brabant Pharma offers emPura, Sông Lam Oil, Hupavir Sinecatechin, and Myovit 3.
Who are Brabant Pharma's investors?
Brabant Pharma has 2 investors. Key investors include Zogenix, and Aquarius Equity Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.